The epidemiology of biopsy-positive giant cell arteritis: Special reference to changes in the age of the population

Rheumatology

Volumn 42, Issue 4, 2003, Pages 549-552

  Nordborg, Claes ^b   Johansson, H ^b   Petursdottir, V ^a   Nordborg, E ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age; Epidemiology; Giant cell arteritis; Incidence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD VESSEL BIOPSY; CALCULATION; CONTROLLED STUDY; FEMALE; GIANT CELL ARTERITIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; SWEDEN;

AGE DISTRIBUTION; AGED; BIOPSY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; SWEDEN; TEMPORAL ARTERITIS;

EID: 0344837888     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg172     Document Type: Article

References (17)

1. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathological analysis. Arthritis Rheum 1994;37:1007-12.
2. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-9.
3. Franzén P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region in Finland: An epidemiologic, clinical and pathologic study, 1984-88, J Rheumatol 1992;19:273-6.
4. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: A prospective study 1987-94. J Rheumatol 1997;24:1739-43.
5. Gran JT, Myklebust G. The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis: a prospective study of 231 cases. Rheumatology 2000;39:283-7.
6. Haugeberg G, Quist Paulsen P, Bruun Bie R. Temporal arteritis in Vest Agder County in Southern Norway: Incidence and clinical findings. J Rheumatol 2000;27:2624-7.
7. Nordborg C, Nordborg E, Petursdottir V. Giant cell arteritis. Epidemiology, etiology and pathogenesis. APMIS 2000;108:713-24.
8. Gonzales Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez Camblor B, Sanches Andrade A. Giant cell arteritis in Mediterranean countries: comment on the article by Salvarani et al. Arthritis Rheum 1992;35:1249-50.
9. Nordborg E, Bengtsson BA. Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med 1990;227:233-6.
10. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 1999;38:1208-12.
11. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
12. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
13. Lie JT. When is arteritis of the temporal arteries not temporal arteritis? J Rheumatol 1994;21:186-9.
14. Östberg G. On arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand (A) 1973;237:1-59.
15. Statistical Year Book of Göteborg (Statistisk Årsbok Göteborg). Göteborg Municipal Office (Göteborgs Stadskansli), 1977-1996.
16. Lie JT, Brown AL, Carter ET. Spectrum of aging changes in temporal arteries. Arch Pathol 1970;90:278-85.
17. Nordborg C, Nordborg E, Petursdottir V, Fyhr I-M. Calcification of the internal elastic membrane in temporal arteries: its relation to age and gender. Clin Exp Rheumatol 2001;19:565-8.